Page last updated: 2024-08-17

quinoxalines and Depressive Disorder, Major

quinoxalines has been researched along with Depressive Disorder, Major in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (37.50)	29.6817
2010's	4 (50.00)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Bastian, J; Bauer, AM; Fox, EN; Gollan, JK; Hitsman, B; Hole, A; Huffman, MD; Khan, SS; Leone, FT; Lubitz, SF; Mohr, DC; Niaura, R; Papandonatos, GD; Schnoll, RA; Veluz-Wilkins, AK; Wileyto, EP	1
Anthenelli, RM; Dubrava, SJ; Morris, C; Ramey, TS; Russ, C; Tsilkos, K; Yunis, C	1
Cinciripini, PM; Karam-Hage, M	1
Popkin, MK	1
Nadeem, SS; Pirmoradi, P; Roshan, S	1
Lyon, GJ	1
Díez-Alarcia, R; García-Sevilla, JA; González-Maeso, J; Meana, JJ; Pazos, A; Pilar-Cuéllar, F; Valdizán, EM	1

Trials

2 trial(s) available for quinoxalines and Depressive Disorder, Major

Article	Year
Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trial. Addiction (Abingdon, England), 2023, Volume: 118, Issue:9 Topics: Adult; Benzazepines; Depressive Disorder, Major; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2023
Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. Annals of internal medicine, 2013, Sep-17, Volume: 159, Issue:6 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Benzazepines; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicidal Ideation; Treatment Outcome; Varenicline; Young Adult	2013

Article

Year

Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trial.

Addiction (Abingdon, England), 2023, Volume: 118, Issue:9

Topics: Adult; Benzazepines; Depressive Disorder, Major; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline

2023

Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial.

Annals of internal medicine, 2013, Sep-17, Volume: 159, Issue:6

Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Benzazepines; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicidal Ideation; Treatment Outcome; Varenicline; Young Adult

2013

Other Studies

6 other study(ies) available for quinoxalines and Depressive Disorder, Major

Article	Year
Summaries for patients. Does varenicline help people with depression quit smoking? Annals of internal medicine, 2013, Sep-17, Volume: 159, Issue:6 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Benzazepines; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicidal Ideation; Treatment Outcome; Varenicline; Young Adult	2013
Study suggests varenicline safe and effective among adults with stable depression. Evidence-based medicine, 2014, Volume: 19, Issue:3 Topics: Benzazepines; Depressive Disorder, Major; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation	2014
Exacerbation of recurrent depression as a result of treatment with varenicline. The American journal of psychiatry, 2008, Volume: 165, Issue:6 Topics: Aged; Benzazepines; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking Cessation; Varenicline	2008
Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Sep-01, Volume: 65, Issue:17 Topics: Adult; Alcoholism; Benzazepines; Depressive Disorder, Major; Humans; Male; Mental Disorders; Nervous System Diseases; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline	2008
Possible varenicline-induced paranoia and irritability in a patient with major depressive disorder, borderline personality disorder, and methamphetamine abuse in remission. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:6 Topics: Adult; Amphetamine-Related Disorders; Benzazepines; Borderline Personality Disorder; Depressive Disorder, Major; Drug Partial Agonism; Female; Humans; Irritable Mood; Methamphetamine; Nicotinic Agonists; Paranoid Disorders; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline	2008
α₂-Adrenoceptor functionality in postmortem frontal cortex of depressed suicide victims. Biological psychiatry, 2010, Nov-01, Volume: 68, Issue:9 Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Brimonidine Tartrate; Depressive Disorder, Major; Female; Frontal Lobe; GTP-Binding Proteins; Humans; Male; Middle Aged; Quinoxalines; Radioligand Assay; Receptors, Adrenergic, alpha-2; Signal Transduction; Suicide	2010